MedySapiens

MedySapiens is an AI genomics company developing MedyCVi, a clinical decision support software for rare disease diagnosis. The platform analyzes WES/WGS genomic data and patient phenotype information, using AI modules for variant prioritization, pathogenicity interpretation and literature search. Founded in 2016, the company is validating and commercializing its solution with hospitals in Korea and pursuing pilots and partnerships in overseas healthcare markets.